2023-03385: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Reopening of the Comment Period
Public comment closed .
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
The Food and Drug Administration (FDA or Agency) is reopening the comment period for the notice entitled "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry," published in the Federal Register of November 18, 2022. The Agency is taking this action to allow interested persons additional time to submit comments.
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →